Phase 3 Vitiligo Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Incyte Corporation180 enrolled99 locationsNCT06548360
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
NonSegmental Vitiligo
Incyte Corporation250 enrolled86 locationsNCT06804811
Recruiting
Phase 3
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
Vitiligo
Pfizer400 enrolled74 locationsNCT06163326
Recruiting
Phase 2Phase 3
Vitiligo, New Treatment and Serum s100B
Vitiligo, Generalized
South Valley University50 enrolled1 locationNCT06768840
Recruiting
Phase 2Phase 3
Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus
Vitiligo
Hospital Authority, Hong Kong20 enrolled1 locationNCT06719024